Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

Endocrine pathology - 1 Mar 2012

Nölting Svenja, Grossman Ashley B

Abstract excerpt

There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of these tumors. A detailed understanding of the molecular pathway alterations giving rise to pheochromocytomas and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Adrenal Gland Neoplasms
Share to Cancer, Hypoxia, and Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Transformation, Neoplastic

Share to Mutation

Share to Paraganglioma

Share to Pheochromocytoma

Share to Signal Transduction

Source

Identifiers

PMID: 22391976
DOI: 10.1007/s12022-012-9199-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.PMID 22391976Read ↗

Molecular markers of paragangliomas/pheochromocytomas.Semantic proximity Read ↗

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.Semantic proximity Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

Pheochromocytoma: implications in tumorigenesis and the actual management.Semantic proximity Read ↗

Personalized Management of Pheochromocytoma and Paraganglioma.Semantic proximity Read ↗

New insights on the pathogenesis of paraganglioma and pheochromocytomaSemantic proximity Read ↗

Genetic bases of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Genomic Landscape of Pheochromocytoma and Paraganglioma.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.Semantic proximity Read ↗

Update on Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.Semantic proximity Read ↗

Genetics of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.